Lab business > Market analysis

ISA releases Issues Paper for Australian innovation

27 March, 2017

Innovation and Science Australia has released the 2030 Strategic Plan Issues Paper as part of its plan to drive the national conversation around the future of Australian innovation, science and research.


National Science Statement released

24 March, 2017

Arthur Sinodinos has unveiled the National Science Statement, articulating the government's vision and objectives for Australian science.


6 key challenges for Australian innovation

16 March, 2017

Innovation and Science Australia (ISA) Chair Bill Ferris has identified the six key innovation challenges Australia must address in order to become a top-tier innovation nation.


World biosurgery market expected to reach over $12.7bn by 2022

17 June, 2016

The world biosurgery market is expected to reach almost $12.76 billion by 2022 with a CAGR of 8.1% from 2015 to 2022, according to a report by Allied Market Research.


Call for increased research-business collaboration

11 March, 2016

Bill Ferris AC has told Australia's university leaders that increasing collaboration for commercialisation of research is both desirable and achievable.


Report calls for fairer pathology payments

22 February, 2016

The Grattan Institute has released a report calling for the government to change the way it pays for pathology testing, in a move which would save up to $175 million a year.


Australia's research output is improving, says report

08 December, 2015

'State of Australian University Research 2015–16' presents the outcomes of the Excellence in Research for Australia 2015 evaluations and details the quality of Australian university research benchmarked against world standards.


Introducing the Science Next Collaborative

07 August, 2015 by Sigma-Aldrich

In order to empower the latest generation of scientists to better commercialise their research, Sigma-Aldrich has spearheaded a new initiative that forges a dynamic partnership between industry and academia.


Budget cuts are harder if people know the benefits of research

24 April, 2015 by Maggie Hardy, The University of Queensland

An old academic joke you start to hear around federal budget time goes something like this: "Researchers could strike but no one would care, because no one would know we've gone until 10 or 15 years later."


Measuring the value of science: it's not always about the money

17 April, 2015 by Rod Lamberts, Australian National University

It's perfectly sensible and understandable that science (and related sectors) would feel the need to account for themselves in financial or economic terms. But in doing this we need to be wary of getting lulled into believing that this is the only - or worse, the best - way of attributing value to science.


Mid-cap biotech companies increase revenues to $26.5 billion

09 April, 2015

Research and consulting firm GlobalData has released a report comparing the competitive positions of 35 mid-cap biotechnology companies, finding an increase in combined total revenues from $24.8 billion in 2013 to $26.5 billion in 2014.


Why is there no generic insulin?

23 March, 2015

Researchers from Johns Hopkins University have delved into the history of the diabetes drug insulin in the hope of understanding why a generic version has never been made available in the US.


Why is there no generic insulin?

23 March, 2015

Researchers from Johns Hopkins University have delved into the history of the diabetes drug insulin in the hope of understanding why a generic version has never been made available in the US.


BioMeter shows re-emergence of late-stage biotech deals

28 October, 2014

Law firm Morrison & Foerster (MoFo) has released its Q3 edition of BioMeter. The quarterly report measures the health of the biotech industry.


There are no free rides to the future: Australia's Chief Scientist

14 August, 2014 by Ian Chubb, Office of the Chief Scientist

This is a transcript of the 2014 Jack Beale Lecture on the Global Environment, hosted at the University of New South Wales.


  • All content Copyright © 2021 Westwick-Farrow Pty Ltd